Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$70.86 - $89.93 $12,683 - $16,097
-179 Reduced 9.79%
1,650 $122,000
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $5,133 - $9,222
96 Added 5.54%
1,829 $100,000
Q2 2023

Aug 10, 2023

BUY
$66.23 - $88.73 $114,776 - $153,769
1,733 New
1,733 $145,000
Q4 2022

Jun 14, 2023

BUY
$39.08 - $64.29 $71,907 - $118,293
1,840 New
1,840 $114 Million
Q3 2022

Jun 14, 2023

BUY
$31.56 - $55.75 $58,070 - $102,580
1,840 New
1,840 $76.8 Million
Q2 2022

Jun 20, 2023

BUY
$20.56 - $32.15 $37,830 - $59,156
1,840 New
1,840 $57,000
Q1 2022

Jun 20, 2023

BUY
$12.58 - $26.94 $23,147 - $49,569
1,840 New
1,840 $49,000
Q1 2022

Mar 30, 2023

SELL
$12.58 - $26.94 $79,342 - $169,910
-6,307 Reduced 77.41%
1,840 $49,000
Q1 2022

May 12, 2022

SELL
$12.58 - $26.94 $79,342 - $169,910
-6,307 Reduced 77.41%
1,840 $50,000
Q4 2021

Jun 21, 2023

BUY
$19.16 - $32.68 $156,096 - $266,243
8,147 New
8,147 $156,000
Q3 2021

Jun 21, 2023

BUY
$25.92 - $34.51 $211,170 - $281,152
8,147 New
8,147 $269,000
Q2 2021

Mar 30, 2023

BUY
$21.63 - $40.07 $9,711 - $17,991
449 Added 5.83%
8,147 $270,000
Q2 2021

Aug 16, 2021

BUY
$21.63 - $40.07 $176,046 - $326,129
8,139 Added 101737.5%
8,147 $270,000
Q1 2021

Jun 26, 2023

BUY
$17.75 - $47.82 $136,639 - $368,118
7,698 New
7,698 $319 Million
Q1 2021

Mar 30, 2023

SELL
$17.75 - $47.82 $7,224 - $19,462
-407 Reduced 5.02%
7,698 $319,000
Q1 2021

May 14, 2021

SELL
$17.75 - $47.82 $143,721 - $387,198
-8,097 Reduced 99.9%
8 $319,000
Q4 2020

Jun 22, 2023

BUY
$11.91 - $19.9 $96,530 - $161,289
8,105 New
8,105 $161,000
Q3 2020

Jun 26, 2023

BUY
$13.78 - $18.84 $111,686 - $152,698
8,105 New
8,105 $111,000
Q3 2020

Mar 30, 2023

BUY
$13.78 - $18.84 $29,075 - $39,752
2,110 Added 35.2%
8,105 $111,000
Q3 2020

Nov 13, 2020

BUY
$13.78 - $18.84 $29,075 - $39,752
2,110 Added 35.2%
8,105 $112,000
Q2 2020

Jun 26, 2023

BUY
$11.66 - $18.26 $69,901 - $109,468
5,995 New
5,995 $107,000
Q2 2020

Mar 30, 2023

BUY
$11.66 - $18.26 $8,395 - $13,147
720 Added 13.65%
5,995 $107,000
Q2 2020

Aug 14, 2020

BUY
$11.66 - $18.26 $8,395 - $13,147
720 Added 13.65%
5,995 $107,000
Q1 2020

Jul 12, 2023

BUY
$10.5 - $20.2 $55,387 - $106,555
5,275 New
5,275 $63,000
Q4 2019

Jul 12, 2023

BUY
$16.61 - $21.64 $87,617 - $114,151
5,275 New
5,275 $100,000
Q4 2019

Mar 30, 2023

BUY
$16.61 - $21.64 $57,055 - $74,333
3,435 Added 186.68%
5,275 $100,000
Q4 2019

Feb 14, 2020

BUY
$16.61 - $21.64 $87,617 - $114,151
5,275 New
5,275 $100,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.29B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.